Fortrea Holdings (STU:K67) FFO


STU:K67 Fortrea Holdings Inc STU:K67
38 GF Score
Price €15.40
GF Value €15.62
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is Fortrea Holdings FFO?

FFO (Funds from operations) only applies to REITs.

STU:K67
38GF Score
Fortrea Holdings Inc STU:K67
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Fortrea Holdings (STU:K67) Overvalued in 2026?

Based on GuruFocus' analysis, Fortrea Holdings stock appears to be undervalued. The current stock price of €15.40 is trading 1.4% below its estimated GF Value™ of €15.62. GuruFocus considers Fortrea Holdings to be Fairly Valued.

Key valuation signals for STU:K67:

  • FFO:
  • GF Value™: €15.62 vs. price of €15.40 (1.4% below fair value)
  • GF Score™: 38/100 with 7 warning signs

No single metric tells the full story. See the STU:K67 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Fortrea Holdings Business Description

Other Exchanges FTRE:USA
Address 8 Moore Drive, Durham, NC, USA, 27713
Fortrea is a global, late-stage contract research organization that provides comprehensive phase 1 through phase 4 clinical trial management, clinical pharmacology, and patient access solutions. The company works with emerging and large biopharma, medical device, and diagnostic companies to run their clinical trials as a functional-service provider, full-service provider, and offers hybrid trials. In 2023, Fortrea was formed as an independent, publicly traded company after Labcorp spun off its clinical development business, which it acquired via its purchase of Covance in 2015 for $6.1 billion.
38GF Score

Get the complete analysis for STU:K67

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€15.40
Price
€15.62
GF Value